Drugs / CKD-382
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05108038 | Oct 2021 → Feb 2022 | gastroesophageal reflux disease | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
| Phase 1 | NCT04703374 | Sep 2020 → Sep 2021 | gastroesophageal reflux disease | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-382 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04703374 ↗ |